Project 2VIDA! SARS-CoV-2 Vaccine Intervention Delivery for Adults in Southern California
项目2VIDA!
基本信息
- 批准号:10397166
- 负责人:
- 金额:$ 59.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-23 至 2026-01-31
- 项目状态:未结题
- 来源:
- 关键词:18 year old2019-nCoVAddressAdultAffectAfrican AmericanAreaAwarenessBehaviorBeliefBenefits and RisksBiological FactorsCOVID-19COVID-19 impactCOVID-19 interventionCOVID-19 mortalityCOVID-19 vaccinationCOVID-19 vaccineCaliforniaCenters for Disease Control and Prevention (U.S.)Cessation of lifeCharacteristicsClient satisfactionCommunitiesCommunity HealthCommunity OutreachCountryCountyDataEducationEssential workerFrightGenerationsGeneticGeographic LocationsGovernmentHandwashingHealthHealth PromotionHealthcareHomeHuman RightsImmunizationImmunization ProgramsIndividualInfectionInterventionKnowledgeLatinoLatinxLatinx populationMasksMedicalMethodsModelingNatureNeighborhood Health CenterNot Hispanic or LatinoOccupationsOutcomeParticipantPerceptionPersonsPhasePoliciesPopulationPreventionPreventiveRandomized Controlled TrialsRecommendationRecording of previous eventsReportingResearchSeriesServicesSiteSocial DistanceStrategic PlanningTimeTrustUnited StatesUnited States National Institutes of HealthVaccinationVaccinesVirusVulnerable PopulationsWorld Health Organizationacceptability and feasibilityadverse outcomebasecommunity based participatory researchcontextual factorsdemographicsethnic minorityevidence baseexperiencefollow-uphealth care availabilityhealth care service utilizationhealth disparityhospitalization ratesimplementation interventionimprovedindicated preventioninfection rateinterestintervention deliveryintervention effectintervention refinementpandemic diseaseparticipant retentionpeople of colorpreventracial and ethnicracial minorityracismrecruitsatisfactionscale upsocialsocial exclusionsocial factorssociodemographicsstandard of careuptakevaccination protocolvaccine acceptancevaccine accessvaccine hesitancyworking group
项目摘要
PROJECT SUMMARY
As of January 2021, the World Health Organization (WHO) reports that 89 million cases of COVID-19 (SARS-
CoV-2) have been confirmed and have resulted in more than 1.9 million deaths globally. Currently, the United
States (U.S.) is the country with the largest number of infections and deaths due to COVID-19, with a total of
22 million infections and 373,167 deaths. Furthermore, early findings that have examined COVID-19
demographics show that racial and ethnic minorities in the U.S. are bearing a disproportionate number of
COVID-19 cases and deaths irrespective of geographic region. While there's no evidence that people of color
(POC) have genetic or biological factors that make them more likely to be affected by COVID-19, they are
more likely to have underlying health conditions, live in multi-generational homes, live in densely populated
areas, have limited access to healthcare, and have jobs that are considered essential and involve interaction
with the public. All of these factors contribute to higher rates of infection and adverse outcomes due to COVID-19. Although COVID-19 preventive behaviors such as hand washing, mask wearing, and social distancing
have been shown to be effective in curbing the spread of the virus, acceptance and uptake of COVID-19
vaccines will be instrumental to ending the pandemic. However, public confidence in vaccination is fragile,
especially among racial and ethnic minorities. To this end, we have formed an intervention working group
comprised of representatives from community and academic organizations to address challenges in COVID-19
vaccination uptake among Latinx and African American (AA) communities in Southern California by using a
community-based participatory research (CBPR) approach. Project 2VIDA! (SARS-CoV-2 Vaccine Intervention
Delivery for Adults in Southern California), is a multilevel intervention to address individual, social, and
contextual factors related to access to, and acceptance of, the COVID-19 vaccine among Latinx and AA adults
(>18 years old) across six highly affected communities in Southeast San Diego. 2VIDA! seeks to implement
and assess a COVID-19 vaccination protocol to increase interest and uptake of COVID-19 vaccine, provide
COVID-19 vaccines in the community, and establish a model for the rapid vaccination of Latino and AA adults
that could be generalizable to other highly affected communities. 2VIDA! builds on our previous CBPR efforts
and centers on conducting COVID-19 community outreach and health promotion, Individual awareness and
education, and linkages to medical and supportive services and offering the COVID-19 vaccine to Latinx and
AA adults (>18 years old) in community health centers (CHC) and mini-vaccination stations in communities
highly impacted by the pandemic in San Diego County.
项目概要
截至 2021 年 1 月,世界卫生组织 (WHO) 报告称,已有 8900 万例 COVID-19(SARS-
CoV-2)已得到证实,并已导致全球超过 190 万人死亡。目前,联合国
各州(美国)是因 COVID-19 感染和死亡人数最多的国家,总共有
2200 万人感染,373,167 人死亡。此外,检查 COVID-19 的早期发现
人口统计数据显示,美国的少数族裔人口数量不成比例。
COVID-19 病例和死亡人数,无论地理区域如何。虽然没有证据表明有色人种
(POC) 具有使他们更容易受到 COVID-19 影响的遗传或生物因素,他们是
更有可能有潜在的健康问题、居住在多代同堂的家庭、居住在人口稠密的地方
地区,获得医疗保健的机会有限,并且从事被认为必不可少且涉及互动的工作
与公众。所有这些因素都会导致 COVID-19 的感染率和不良后果更高。尽管洗手、戴口罩和保持社交距离等 COVID-19 预防行为
已被证明可以有效遏制病毒的传播、COVID-19 的接受和吸收
疫苗将有助于结束这一流行病。然而,公众对疫苗接种的信心却很脆弱,
尤其是在少数种族和族裔中。为此,我们成立了干预工作组
由社区和学术组织的代表组成,共同应对 COVID-19 的挑战
南加州拉丁裔和非裔美国人 (AA) 社区的疫苗接种情况
基于社区的参与性研究(CBPR)方法。项目2VIDA! (SARS-CoV-2 疫苗干预
南加州成人分娩)是一项多层次干预措施,旨在解决个人、社会和
与拉丁裔和 AA 成年人获取和接受 COVID-19 疫苗相关的背景因素
(> 18 岁)位于圣地亚哥东南部六个受影响严重的社区。 2维达!力求实施
评估 COVID-19 疫苗接种方案,以提高人们对 COVID-19 疫苗的兴趣和使用率,提供
在社区中接种 COVID-19 疫苗,并建立拉丁裔和 AA 成年人快速疫苗接种模型
这可以推广到其他受影响严重的社区。 2维达!以我们之前的 CBPR 努力为基础
并以开展 COVID-19 社区外展和健康促进、个人意识和
教育、与医疗和支持服务的联系以及向拉丁裔和拉丁裔提供 COVID-19 疫苗
社区卫生中心 (CHC) 和社区小型疫苗接种站的 AA 成年人(>18 岁)
圣地亚哥县受疫情影响严重。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Argentina Elisa Noelle Servin其他文献
Argentina Elisa Noelle Servin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Argentina Elisa Noelle Servin', 18)}}的其他基金
Project 2VIDA! SARS-CoV-2 Vaccine Intervention Delivery for Adults in Southern California
项目2VIDA!
- 批准号:
10347120 - 财政年份:2021
- 资助金额:
$ 59.99万 - 项目类别:
Project 2VIDA! SARS-CoV-2 Vaccine Intervention Delivery for Adults in Southern California
项目2VIDA!
- 批准号:
10551898 - 财政年份:2021
- 资助金额:
$ 59.99万 - 项目类别:
Project 2VIDA! SARS-CoV-2 Vaccine Intervention Delivery for Adults in Southern California
项目2VIDA!
- 批准号:
10733348 - 财政年份:2021
- 资助金额:
$ 59.99万 - 项目类别:
Preventing IPV and Reproductive Coercion Among Underserved Adolescents
预防服务不足的青少年中的 IPV 和生殖胁迫
- 批准号:
9894819 - 财政年份:2016
- 资助金额:
$ 59.99万 - 项目类别:
Preventing IPV and Reproductive Coercion Among Underserved Adolescents
预防服务不足的青少年中的 IPV 和生殖胁迫
- 批准号:
9247788 - 财政年份:2016
- 资助金额:
$ 59.99万 - 项目类别:
Preventing IPV and Reproductive Coercion Among Underserved Adolescents
预防服务不足的青少年中的 IPV 和生殖胁迫
- 批准号:
9110075 - 财政年份:2016
- 资助金额:
$ 59.99万 - 项目类别:
相似国自然基金
微米和纳米塑料作用下2019-nCoV抗病毒药物利巴韦林对河蚬的毒性作用机制
- 批准号:
- 批准年份:2021
- 资助金额:10.0 万元
- 项目类别:省市级项目
2019-nCoV感染导致人体淋巴细胞减低机制及其对机体免疫功能影响
- 批准号:82030002
- 批准年份:2020
- 资助金额:135 万元
- 项目类别:专项基金项目
基于人口流动大数据的新型冠状病毒(2019-nCoV)输出感染风险及接触网络传播模型研究
- 批准号:
- 批准年份:2020
- 资助金额:135 万元
- 项目类别:
新型冠状病毒(2019-nCoV)反向遗传系统及啮齿类感染模型的建立与应用
- 批准号:
- 批准年份:2020
- 资助金额:150 万元
- 项目类别:
云南驯养野生动物中新型冠状病毒(2019-nCoV)溯源调查与验证
- 批准号:
- 批准年份:2020
- 资助金额:140 万元
- 项目类别:
血必净预防2019-nCoV肺炎发生ARDS及机制研究
- 批准号:82041003
- 批准年份:2020
- 资助金额:135 万元
- 项目类别:专项基金项目
新型冠状病毒2019-nCoV复制复合体关键蛋白的功能与潜在药物靶点研究
- 批准号:
- 批准年份:2020
- 资助金额:150 万元
- 项目类别:专项基金项目
2019-nCoV蝙蝠及人群代表性流行株致病能力的比较研究
- 批准号:
- 批准年份:2020
- 资助金额:150 万元
- 项目类别:专项基金项目
人新型冠状病毒2019-nCoV受体利用介导的种间传播和感染机制研究
- 批准号:
- 批准年份:2020
- 资助金额:140 万元
- 项目类别:专项基金项目
2019-nCoV“不典型症状”感染者的宿主因素及其作用机制研究
- 批准号:
- 批准年份:2020
- 资助金额:150 万元
- 项目类别:专项基金项目
相似海外基金
COVID-19 Variant Supplement - Targeting programmed ribosomal frameshifting as a therapeutic strategy against 2019-nCoV
COVID-19 变异补充剂 - 以程序化核糖体移码为目标作为针对 2019-nCoV 的治疗策略
- 批准号:
443173 - 财政年份:2021
- 资助金额:
$ 59.99万 - 项目类别:
Operating Grants
Destigmatizing Chinese Communities in the face of 2019-nCoV: Emergency Management Actions to Address Social Vulnerability in Toronto and Nairobi
面对 2019-nCoV,消除华人社区的污名化:解决多伦多和内罗毕社会脆弱性的应急管理行动
- 批准号:
422610 - 财政年份:2020
- 资助金额:
$ 59.99万 - 项目类别:
Operating Grants
Task A38: Establishment of Small Animal Models for Screening Medical Countermeasures for the 2019 Novel Coronavirus (2019-nCoV)
任务A38:建立用于筛选2019新型冠状病毒(2019-nCoV)医疗对策的小动物模型
- 批准号:
10330359 - 财政年份:2020
- 资助金额:
$ 59.99万 - 项目类别:
Task A38: Establishment of Small Animal Models for Screening Medical Countermeasures for the 2019 Novel Coronavirus (2019-nCoV)
任务A38:建立用于筛选2019新型冠状病毒(2019-nCoV)医疗对策的小动物模型
- 批准号:
10454575 - 财政年份:2020
- 资助金额:
$ 59.99万 - 项目类别:
Task A38: Establishment of Small Animal Models for Screening Medical Countermeasures for the 2019 Novel Coronavirus (2019-nCoV)
任务A38:建立用于筛选2019新型冠状病毒(2019-nCoV)医疗对策的小动物模型
- 批准号:
10454574 - 财政年份:2020
- 资助金额:
$ 59.99万 - 项目类别:
Task A38: Establishment of Small Animal Models for Screening Medical Countermeasures for the 2019 Novel Coronavirus (2019-nCoV)
任务A38:建立用于筛选2019新型冠状病毒(2019-nCoV)医疗对策的小动物模型
- 批准号:
10579807 - 财政年份:2020
- 资助金额:
$ 59.99万 - 项目类别:
Targeting programmed ribosomal frameshifting as a therapeutic strategy against 2019-nCoV
以程序化核糖体移码为目标作为针对 2019-nCoV 的治疗策略
- 批准号:
422724 - 财政年份:2020
- 资助金额:
$ 59.99万 - 项目类别:
Operating Grants
Task A38: Establishment of Small Animal Models for Screening Medical Countermeasures for the 2019 Novel Coronavirus (2019-nCoV)
任务A38:建立用于筛选2019新型冠状病毒(2019-nCoV)医疗对策的小动物模型
- 批准号:
10464972 - 财政年份:2020
- 资助金额:
$ 59.99万 - 项目类别:
Task A38: Establishment of Small Animal Models for Screening MCMs for the 2019 Novel Coronavirus (2019-nCoV)
任务 A38:建立用于筛选 2019 年新型冠状病毒(2019-nCoV)的 MCM 的小动物模型
- 批准号:
10473626 - 财政年份:2020
- 资助金额:
$ 59.99万 - 项目类别:
RAPID Proposal: Psychological distance and risk perception related to the 2019 novel coronavirus (2019-nCoV) outbreak
RAPID提案:与2019年新型冠状病毒(2019-nCoV)爆发相关的心理距离和风险感知
- 批准号:
2020597 - 财政年份:2020
- 资助金额:
$ 59.99万 - 项目类别:
Standard Grant














{{item.name}}会员




